Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
NUPATHE INC. (PATH) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/21/2014 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Certificate of Incorporation of NuPathe Inc",
"Amended and Restated Bylaws of NuPathe Inc"
01/21/2014 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger, by and among Teva",
"Form of Contingent Cash Consideration Agreement, by and among Train Merger Sub, Inc., American Stock Transfer & Trust Company and Teva Pharmaceuticals Industries Ltd",
"Subordinated Promissory Note, issued by NuPathe Inc. to Teva Pharmaceuticals USA Inc",
"Subordination Agreement, by and among Teva Pharmaceuticals USA, Inc., NuPathe Inc. and Hercules Technology Growth Capital, Inc",
"NuPathe Terminates Agreement with Endo and Enters into Agreement to be Acquired by Teva"
01/14/2014 8-K Entry into a Material Definitive Agreement
01/09/2014 8-K Entry into a Material Definitive Agreement
12/16/2013 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Endo Health Solutions Inc., DM Merger Sub Inc. and NuPathe Inc",
"Form of Contingent Cash Consideration Agreement by and among DM Merger Sub Inc., American Stock Transfer & Trust Company and Endo Health Solutions Inc",
"Endo to Acquire Specialty Pharmaceutical Company NuPathe"
11/14/2013 8-K Quarterly results
Docs: "NuPathe Announces Third Quarter 2013 Financial Results and Recent Operational Highlights"
10/15/2013 8-K Entry into a Material Definitive Agreement
09/19/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Lease Agreement, between Liberty Property Limited Partnership and NuPathe Inc"
09/11/2013 8-K Quarterly results
08/08/2013 8-K Quarterly results
Docs: "NuPathe Announces Second Quarter 2013 Financial Results and Recent Operational Highlights"
06/10/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/11/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/14/2012 8-K Other Events
11/27/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Loan and Security Agreement, by and between Hercules Technology Growth Finance, Inc. and NuPathe Inc",
"Secured Promissory Note, issued by NuPathe Inc. in favor of Hercules Technology Growth Finance, Inc",
"Warrant, issued by NuPathe Inc. in favor of Hercules Technology Growth Finance, Inc"
10/23/2012 8-K Asset disposition
Docs: "NuPathe Announces Closing of $28 Million Private Placement and Changes to its Board of Directors"
10/12/2012 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "NuPathe Granted Financial Viability Exception by NASDAQ"
10/09/2012 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "NuPathe Inc. Corporate Presentation"
09/26/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Third Loan Modification Agreement, among NuPathe Inc., MidCap Funding III, LLC and Silicon Valley Bank"
09/26/2012 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Securities Purchase Agreement, among NuPathe Inc. and the investors named therein",
"Form of Certificate of Powers, Designations, Preferences, Rights and Qualifications, Limitations or Restrictions of Series A Preferred Stock",
"Form of Warrant",
"NuPathe Announces $28 Million Private Placement"
08/14/2012 8-K Quarterly results
Docs: "NuPathe Announces Second Quarter 2012 Financial Results and Operational Highlights"
07/30/2012 8-K Form 8-K - Current report
07/25/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NuPathe Appoints Armando Anido as Chief Executive Officer"
06/12/2012 8-K Submission of Matters to a Vote of Security Holders
06/01/2012 8-K Other Events
04/26/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Equipment Purchase Agreement, by and between Automated Engineering, LLC and NuPathe Inc"
03/20/2012 8-K Quarterly results
Docs: "NuPathe Announces Fourth Quarter 2011 Financial Results and Operational Highlights"
11/14/2011 8-K Form 8-K - Current report
10/03/2011 8-K Form 8-K - Current report
10/03/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "NuPathe Reports Positive Top-Line Results from 12-Month, Repeat Use Safety Trial for its Migraine Patch"
08/30/2011 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "FDA Requests Additional Information Regarding NuPathe's Migraine Patch in Complete Response Letter"
08/15/2011 8-K Quarterly results
Docs: "NUPATHE ANNOUNCES SECOND QUARTER 2011 FINANCIAL RESULTS"
08/02/2011 8-K Form 8-K - Current report
06/23/2011 8-K Form 8-K - Current report
06/02/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy